Mati Therapeutics Inc.
Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure
- Conditions
- Interventions
- First Posted Date
- 2021-07-14
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04962009
- Locations
- 🇺🇸
Stiles Eyecare Excellence, Overland Park, Kansas, United States
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
- Conditions
- Interventions
- First Posted Date
- 2020-02-21
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04280653
- Locations
- 🇺🇸
Ophthalmic Consultants of Long Island, Garden City, New York, United States
🇺🇸Cincinnati Eye Institute-Edgewood, Edgewood, Kentucky, United States
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
- Conditions
- Interventions
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT03496467
- Locations
- 🇺🇸
Kerry Solomon, MD, Mount Pleasant, South Carolina, United States
🇺🇸Cincinnati Eye Institute-Edgewood, Edgewood, Kentucky, United States
🇺🇸Ophthalmic Consultants of Long Island, Garden City, New York, United States
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
- Conditions
- Interventions
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT02014142
- Locations
- 🇺🇸
Great Lakes Eye Care, St. Joseph, Michigan, United States
🇺🇸Total Eye Care, Memphis, Tennessee, United States
🇺🇸Abrams Eye Institute, Las Vegas, Nevada, United States
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
- Conditions
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT01481051
- Locations
- 🇺🇸
Sall Research Medical Center, Inc, Artesia, California, United States
🇺🇸West Coast Eye Care Associates, San Diego, California, United States
🇺🇸Coastal Research Associates, LLC, Roswell, Georgia, United States
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2013-09-26
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 77
- Registration Number
- NCT01481077
- Locations
- 🇺🇸
Las Vegas Physicians Research Group, Henderson, Nevada, United States
🇺🇸Total Eye Care, P.A., Memphis, Tennessee, United States
🇺🇸Vold Vision, Springdale, Arkansas, United States
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
- Conditions
- Interventions
- First Posted Date
- 2011-02-01
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 143
- Registration Number
- NCT01287338
- Locations
- 🇨🇦
Cetero Research, Toronto, Ontario, Canada
A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 121
- Registration Number
- NCT01229982
- Locations
- 🇨🇦
QLT Inc., Vancouver, British Columbia, Canada
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
- Conditions
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT01037036
- Locations
- 🇺🇸
Menlo Park, Menlo Park, California, United States
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
- Conditions
- Interventions
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- Mati Therapeutics Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT00967811